No Data
No Data
Hims & Hers Health Shares Are Trading Lower After the Company Reported Q4 Financial Results.
Express News | Hims & Hers Shares Drop 17.3% Premarket After Co Warns It May Stop Selling Compounded Weight-Loss Drugs
Hims & Hers Health Faces Growth Challenges Amid Mixed Financial Performance: Sell Rating Maintained
BTIG Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $85
BTIG Sticks to Their Buy Rating for Hims & Hers Health (HIMS)
Biggest Stock Movers Tuesday: Crypto Stocks, HIMS, ZM, and More
Unlock the Full List
FatCoke : yeh, nice scam on a much stankier muskrat kinna stock that has nothing to stick to its left nut on a down trend. good one pumper but not today![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
FIRE1668 : guru style. hit n run then followes die
ALL IN or DONT IN : sound like jesus, messiah, son of god… mother nature